STAB — STATERA BIOPHARMA INC
STAB (STATERA BIOPHARMA INC) is tracked on HoldingsHub across five years of quarterly 13F filings. 14 funds have reported positions historically, with the sum of their latest reported stakes valued at $79.92K. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2022 | 378.68K | $30.75K | 0.00% | Hold |
| Charles Schwab Investment Management history | Q4 2021 | 12.17K | $28.00K | 0.00% | Hold |
| Northern Trust Corp history | Q4 2022 | 171.11K | $13.89K | 0.00% | Hold |
| Two Sigma Investments history | Q3 2022 | 37.27K | $5.00K | 0.00% | Reduce |
| Citadel Advisors history | Q3 2022 | 18.20K | $2.00K | 0.00% | Reduce |
| UBS Group AG history | Q4 2022 | 2.01K | $161 | 0.00% | Reduce |
| Renaissance Technologies history | Q4 2022 | 722.39K | $59 | 0.00% | Reduce |
| Wells Fargo & Co history | Q4 2022 | 287 | $23 | 0.00% | Reduce |
| Geode Capital Management history | Q4 2022 | 130.77K | $10 | 0.00% | Hold |
| Bank of America Corp history | Q4 2022 | 100 | $8 | 0.00% | Hold |
| Morgan Stanley history | Q4 2022 | 60 | $5 | 0.00% | Add |
| Millennium Management history | Q4 2022 | 58.58K | $5 | 0.00% | Add |
| T. Rowe Price Associates history | Q4 2022 | 61.20K | $5 | 0.00% | Hold |
| Fidelity Management & Research (FMR) history | Q3 2021 | 46 | $0 | — | New |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 14 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 |
|---|---|---|---|---|---|---|
| Vanguard Group | 426.34K | 417.36K | 389.11K | 389.11K | 378.68K | 378.68K |
| Northern Trust Corp | 24.94K | 39.26K | 171.11K | 171.11K | 171.11K | 171.11K |
| UBS Group AG | 19.47K | — | 118.67K | 8.55K | 97.90K | 2.01K |
| Renaissance Technologies | 114.20K | 206.03K | 171.92K | 1.64M | 1.36M | 722.39K |
| Wells Fargo & Co | 156 | 148 | 173 | 271 | 762 | 287 |
| Geode Capital Management | 77.70K | 130.77K | 130.77K | 130.77K | 130.77K | 130.77K |
| Bank of America Corp | 100 | 245 | 100 | 100 | 100 | 100 |
| Morgan Stanley | 6.00K | 6.01K | 6.00K | 4 | 1 | 60 |
| Millennium Management | — | — | — | 18.70K | 25.35K | 58.58K |
| T. Rowe Price Associates | — | — | 11.70K | 61.20K | 61.20K | 61.20K |
| Citadel Advisors | — | 10.10K | 20.37K | 19.20K | 18.20K | — |
| Fidelity Management & Research (FMR) | 46 | — | — | — | — | — |
| Two Sigma Investments | — | — | 58.52K | 41.08K | 37.27K | — |
| Charles Schwab Investment Management | 12.17K | 12.17K | — | — | — | — |